SCHEMBL16110901

SCHEMBL16110901

CC(N)OC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16111527 0.97
SCHEMBL9240397 0.76
SCHEMBL20865416 0.75
SCHEMBL18647976 0.75
SCHEMBL20374436 0.75
SCHEMBL31299926 0.72
SCHEMBL17729834 0.72
SCHEMBL247394 0.72
SCHEMBL16226274 0.69
SCHEMBL149017 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113874426-B Water-soluble film and package 株式会社可乐丽 2025-03-28 CN disclosed
EP-4192831-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2023-06-14 EP disclosed
CN-113874426-A Water-soluble film and package 株式会社可乐丽 2021-12-31 CN disclosed
EP-3865135-A2 NEUROACTIVE STEROIDS FOR USE IN THERAPY Sage Therapeutics, Inc. (US) 2021-08-18 EP disclosed
WO-2020218321-A1 WATER-SOLUBLE FILM AND PACKAGING 株式会社クラレ 2020-10-29 WO disclosed
EP-2978752-A1 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2016-02-03 EP disclosed
WO-2014160810-A1 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-10-02 WO disclosed